Management of Prostate DiseasesProfessional Communications, 2004 - 192 Seiten Guidelines for clinicians in making the initial evaluation of the patient with prostatic disease. Covers prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Treatment options for BPH, including drug therapy, surgery, prostate stents, laser, and microwave therapy, are discussed with case study illustrations. |
Andere Ausgaben - Alle anzeigen
Häufige Begriffe und Wortgruppen
5a-reductase Abbreviations ablation acute bacterial prostatitis agents alfuzosin androgen antiandrogen AUA symptom score benign prostatic hyperplasia bicalutamide biopsy bladder neck blocker catheter CHANGES FROM BASELINE ciprofloxacin Clin clinical CPPS decreased diagnosis disease Dosage dose double-blind doxazosin dutasteride efficacy and safety evaluation expressed prostatic secretions external beam Figure finasteride flutamide hormone improvement increased inhibitor ketoconazole laser leuprolide levofloxacin LHRH Lobe luteinizing MEAN CHANGES metastatic mg bid mg/day mL/second multicenter ng/mL obstruction open-label extension patients Peak Urinary Flow placebo placebo-controlled pros prostate cancer prostate volume prostate-specific antigen PSA level radical prostatectomy receptors rectal examination renal Roehrborn CG saw palmetto Score and Peak serum side effects studies surgery symptomatic tamsulosin tatic terazosin testosterone therapy tion tissue Total Symptom Score transurethral resection treatment of benign trials TUIP tumor TURP urethral Urinary Flow Rate urinary retention urine Urol Urology voiding Walsh PC weeks